BACKGROUND: An important goal in medicine is to provide patients with individualised and personalised treatment. Personalised medicine is making an important contribution. AIM: To summarise developments in the field of personalised medicine in rheumatology. METHOD: We review the results so far and discuss what developments we can expect in the future. RESULTS: In rheumatology there have been advances in three main areas: 1. therapeutic drug monitoring (measuring medication levels and using the results as a guide for further treatment); 2. the use of biomarkers to determine which drugs should be selected or which should be stopped; 3. involvement of the patient's own observations concerning treatment options. CONCLUSION: Personalised medicine is being used increasingly in rheumatology.
BACKGROUND: An important goal in medicine is to provide patients with individualised and personalised treatment. Personalised medicine is making an important contribution. AIM: To summarise developments in the field of personalised medicine in rheumatology. METHOD: We review the results so far and discuss what developments we can expect in the future. RESULTS: In rheumatology there have been advances in three main areas: 1. therapeutic drug monitoring (measuring medication levels and using the results as a guide for further treatment); 2. the use of biomarkers to determine which drugs should be selected or which should be stopped; 3. involvement of the patient's own observations concerning treatment options. CONCLUSION: Personalised medicine is being used increasingly in rheumatology.
Authors: Michael T Hirschmann; Niklaus F Friederich; Roland Becker; Jon Karlsson Journal: Knee Surg Sports Traumatol Arthrosc Date: 2019-03-13 Impact factor: 4.342
Authors: Emily L Gulliver; Remy B Young; Michelle Chonwerawong; Gemma L D'Adamo; Tamblyn Thomason; James T Widdop; Emily L Rutten; Vanessa Rossetto Marcelino; Robert V Bryant; Samuel P Costello; Claire L O'Brien; Georgina L Hold; Edward M Giles; Samuel C Forster Journal: Aliment Pharmacol Ther Date: 2022-05-24 Impact factor: 9.524